Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

12
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
12
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

167
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
167
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

18
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
18
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

585
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
585
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

27
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
27

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative anesthetic management for resection of giant retroperitoneal tumors.

Frontiers in oncology·2026
Same author

Strain-Based Monitoring Methodology and Numerical Validation for the Evaluation of Transverse Connection Condition in Precast Multi-Girder Bridges.

Sensors (Basel, Switzerland)·2026
Same author

Microbiome histidine competition mediates dietary control of systemic imidazole propionate.

bioRxiv : the preprint server for biology·2026
Same author

Correction: Camel Whey protein ameliorates type Ⅰ diabetic cardiomyopathy by mitigating oxidative stress, inflammation and apoptosis.

Food science of animal resources·2026
Same author

Both internal and external switches jointly determine seed dormancy and germination.

Plant science : an international journal of experimental plant biology·2026
Same author

Chemical methodologies for Direct-to-Biology library synthesis.

European journal of medicinal chemistry·2026

Related Experiment Video

Updated: Jul 12, 2025

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.1K

KDM2A Deficiency in the Liver Promotes Abnormal Liver Function and Potential Liver Damage.

Matthew Martin1, Aishat Motolani1, Hyeong-Geug Kim2

  • 1Department of Pharmacology and Toxicology, Indiana University School of Medicine, 635 Barnhill Drive, Indianapolis, IN 46202, USA.

Biomolecules
|October 28, 2023
PubMed
Summary

Liver-specific deficiency of lysine demethylase 2A (KDM2A) in mice increased liver inflammation and dysfunction. This highlights KDM2A

Keywords:
KDM2ANF-κBdiabeteslivermetabolism

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

11.8K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.2K

Related Experiment Videos

Last Updated: Jul 12, 2025

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat
09:27

The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat

Published on: June 17, 2016

12.1K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

11.8K
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.2K

Area of Science:

  • Metabolic regulation
  • Liver physiology
  • Inflammation pathways

Background:

  • Liver metabolic dysfunction is linked to diabetes and metabolic disorders.
  • Nuclear factor-kappa B (NF-κB) signaling activation drives liver inflammation.
  • Lysine demethylase 2A (KDM2A) is a known negative regulator of NF-κB.

Purpose of the Study:

  • To investigate the role of KDM2A in liver function.
  • To establish and utilize a novel liver-specific KDM2A knockout mouse model.

Main Methods:

  • Generated an inducible liver-specific KDM2A knockout mouse model (Alb-Cre-Kdm2a).
  • Analyzed liver function markers (ALT, triglycerides, glycogen) under normal and high-fat diet (HFD) conditions.
  • Assessed NF-κB target gene expression and immune cell infiltration.

Main Results:

  • KDM2A knockout mice showed elevated ALT, triglycerides, and liver glycogen levels.
  • These metabolic alterations were exacerbated under HFD.
  • Increased NF-κB target gene expression and immune cell infiltration were observed in knockout mice.

Conclusions:

  • Liver-specific KDM2A deficiency promotes liver inflammation, potentially via NF-κB activation.
  • KDM2A deficiency leads to liver dysfunction and metabolic abnormalities.
  • The developed KDM2A knockout mouse model is valuable for studying liver metabolic diseases.